Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.
You're using version {0} of the web browser {1}. This means that the content or functionality of our website may be limited or unavailable. We recommend that you upgrade your browser to optimise your experience of our website.
PharmocogenOmics for minimized Risk and better Efficacy in Children on highdose Steroid Treatment
| Reference number | 2025-00304 |
| Coordinator | Karolinska Institutet - Institutet f miljömedicin IMM, Avd f interativ metabolomik |
| Funding from Vinnova | SEK 2 985 000 |
| Project duration | April 2026 - March 2029 |
| Status | Ongoing |
| Venture | European partnership for Personalised Medicine |
| Call | International collaboration in pharmacogenomics in personalised medicine |
Last updated 4 December 2025
Reference number 2025-00304
